The PE Ratio as of November 2024 (TTM) for Aileron Therapeutics, Inc. (ALRN) is -0.86

According to Aileron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.86. This represents a change of -51.16% compared to the average of -1.76 of the last 4 quarters.

Aileron Therapeutics, Inc. (ALRN) Historical PE Ratio (quarterly & annually)

How has ALRN PE Ratio performed in the past?

The mean historical PE Ratio of Aileron Therapeutics, Inc. over the last ten years is -2.52. The current -0.86 PE Ratio has changed 3.32% with respect to the historical average. Over the past ten years (40 quarters), ALRN's PE Ratio was at its highest in in the June 2017 quarter at -0.26. The PE Ratio was at its lowest in in the March 2017 quarter at -8.72.

Aileron Therapeutics, Inc. (ALRN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aileron Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aileron Therapeutics, Inc. (ALRN) Average PE Ratio

How has ALRN PE Ratio performed in the past?

The current PE Ratio of Aileron Therapeutics, Inc. (ALRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aileron Therapeutics, Inc. (ALRN) PE Ratio vs. Peers

How is ALRN’s PE Ratio compared to its peers?

Aileron Therapeutics, Inc.’s PE Ratio is less than Applied Molecular Transport Inc. (-0.43), greater than Catalyst Biosciences, Inc. (-4.80), less than Bio-Path Holdings, Inc. (-0.24), greater than Benitec Biopharma Inc. (-5.35), less than Artelo Biosciences, Inc. (-0.81), less than Histogen Inc. (-0.01), less than Curis, Inc. (-0.53), less than Timber Pharmaceuticals, Inc. (-0.04), less than Evelo Biosciences, Inc. (-0.00), less than Aptinyx Inc. (-0.06), less than Magenta Therapeutics, Inc. (-0.15), less than ABVC BioPharma, Inc. (-0.83), greater than Neoleukin Therapeutics, Inc. (-5.86), less than CytomX Therapeutics, Inc. (5.48), greater than Assembly Biosciences, Inc. (-2.34), greater than Instil Bio, Inc. (-2.26), greater than Nuvation Bio Inc. (-1.44), less than First Wave BioPharma, Inc. (-0.85), less than Salarius Pharmaceuticals, Inc. (-0.35), less than SAB Biotherapeutics, Inc. (-0.64), less than Vaccinex, Inc. (-0.39), less than GeoVax Labs, Inc. (-0.78),

Build a custom stock screener for Aileron Therapeutics, Inc. (ALRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aileron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aileron Therapeutics, Inc. (ALRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aileron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.